Business news

Epilepsy treatments head Bod Australia’s priorities

Bod Australia is looking to cash in on expected demand for cannabis-based treatments through plans to import an oil used to help children with epilepsy.

This medical marijuana start-up uses artificial intelligence to find which strain is best for you

Artificial intelligence is being used to improve banking, marketing, the legal field — and now to find which one of the more than 30,000 strains of medical marijuana is best for you.

Chapmans investment in AZ Pharmaceuticals Inc facilitates entry into medicinal cannabis market

Diversified investment company focused on high-growth market segments, Chapmans (ASX: CHP) announced on Friday that its specialist wholly owned medicinal cannabis subsidiary, Cannabis Investments Limited (CIL), had entered into a Term Sheet with AZ Pharmaceuticals Inc.

Growing demand drives flurry of Aussie–Israeli cannabis partnerships

An Israeli company will partner with an Australian one to help boost clinical education opportunities around medical cannabis.

Cannabis Science releases chronic pain transdermal patches

Cannabis Science, Inc., a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce that its new product-development plans are well underway with the release of the first batch of the CBIS Transdermal Patch.